NanoSphere Health Sciences Inc.

NSHS

CA63010P2098

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:11:23 2024-05-03 pm EDT			5-day change	1st Jan Change
0.025 ^CAD	0.00%		0.00%	+150.00%

Apr. 30	NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Nanosphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2019

June 15, 2020 at 06:01 pm EDT

NanoSphere Health Sciences Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced total revenue was USD 218,034 compared to USD 37,881 a year ago. Net loss was USD 3.468 million compared to USD 4.514 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.05 a year ago.

Latest news about NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-27	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-17	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	23-04-27	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-24	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-02	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-24	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-25	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	22-04-24	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-29	CI
NanoSphere Health Sciences Inc. announced that it expects to receive CAD 0.234 million in funding	21-09-16	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-30	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-31	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	21-04-29	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-29	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-28	CI
Nanosphere Health Sciences Inc. Announces Earnings Results for the First Quarter Ended March 31, 2020	20-07-15	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-06-15	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	20-06-14	CI
NanoSphere Health Sciences Inc. Announces Resignation of Mark Percival as CEO	20-04-21	CI
NanoSphere Health Sciences Inc. Provides Update on United States Operations	19-12-09	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-28	CI

Chart NanoSphere Health Sciences Inc.

Duration

Period

More charts

Company Profile

NanoSphere Health Sciences Inc. is a nano-biotechnology company. The Company is focused on providing delivery of biologically active compounds through licensing and joint venture arrangements. The Company has created a patented NanoSphere Deliver System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries. Its wholly owned subsidiary is NanoSphere Health Sciences, LLC (NanoSphere LLC). NanoSphere LLC is the Companyâs operating division in the United States.

Sector

Pharmaceuticals

Calendar

2024-05-27 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
NANOSPHERE HEALTH SCIENCES INC.	+150.00%	189K
SUN PHARMACEUTICAL INDUSTRIES LTD.	+22.35%	44.12B
OTSUKA HOLDINGS CO., LTD.	+22.22%	22.61B
SANDOZ GROUP AG	+18.07%	15.11B
CIPLA LIMITED	+15.73%	13.61B
ZYDUS LIFESCIENCES LIMITED	+57.91%	13.34B
ONO PHARMACEUTICAL CO., LTD.	-8.98%	6.94B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.65%	5.75B

Generic Pharmaceuticals